Benstrup E, et al. Efficacy and safety of nintedanib in the elderly patient with IPF. Abstract 1353. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Icotinib versus chemotherapie als adjuvante behandeling stadium II-IIIA EGFR-gemuteerd NSCLC
jan 2022 | Longoncologie